436 related articles for article (PubMed ID: 27267106)
1. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trials.
Jia Y; Zhu H; Leung SW
BMJ Open; 2016 Jun; 6(6):e010142. PubMed ID: 27267106
[TBL] [Abstract][Full Text] [Related]
2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
Chawla N; Anothaisintawee T; Charoenrungrueangchai K; Thaipisuttikul P; McKay GJ; Attia J; Thakkinstian A
BMJ; 2022 Jan; 376():e066084. PubMed ID: 35045991
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
7. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Kennedy SH; Andersen HF; Thase ME
Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
[TBL] [Abstract][Full Text] [Related]
9. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis.
Zhou X; Cipriani A; Furukawa TA; Cuijpers P; Zhang Y; Hetrick SE; Pu J; Yuan S; Del Giovane C; Xie P
BMJ Open; 2018 Jan; 8(1):e018357. PubMed ID: 29306886
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
14. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.
Jakobsen JC; Katakam KK; Schou A; Hellmuth SG; Stallknecht SE; Leth-Møller K; Iversen M; Banke MB; Petersen IJ; Klingenberg SL; Krogh J; Ebert SE; Timm A; Lindschou J; Gluud C
BMC Psychiatry; 2017 Feb; 17(1):58. PubMed ID: 28178949
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
Jakubovski E; Varigonda AL; Freemantle N; Taylor MJ; Bloch MH
Am J Psychiatry; 2016 Feb; 173(2):174-83. PubMed ID: 26552940
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews.
Ghaffari Darab M; Hedayati A; Khorasani E; Bayati M; Keshavarz K
Int J Psychiatry Clin Pract; 2020 Nov; 24(4):357-370. PubMed ID: 32667275
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.
Rahimi R; Nikfar S; Abdollahi M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):118-27. PubMed ID: 19028540
[TBL] [Abstract][Full Text] [Related]
20. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
